These days, it hasn't all been sunshine and rainbows for dwelling care suppliers after hitting the general public market.

Nevertheless, BrightSpring Well being Companies (Nasdaq: BTSG) is making an attempt to buck this development.

“We have now strategically positioned BrightSpring to be a key participant within the areas of biggest want in healthcare and in a number of the most enjoyable development markets inside healthcare,” BrightSpring CEO Jon Rousseau stated throughout Thursday's earnings name for the corporate's fourth quarter. “I’m assured that BrightSpring will probably be among the many long-term winners in every of those markets.”

BrightSpring Well being Companies is a Louisville, Kentucky-based supplier of dwelling and community-based providers (HCBS). The corporate serves advanced populations requiring specialised or continual care.

As BrightSpring builds on its latest successes, Rousseau believes it’s effectively positioned to be a pacesetter in dwelling care.

“5% of the inhabitants is liable for 50% of well being care expenditures,” Rousseau stated. “They want higher options and wish a number of providers. And the place they’re, is dwelling. Everybody wants their drugs, everybody wants a physician. Most individuals want providers at dwelling. They don't simply want one service. Most suppliers solely provide one service. We have now the power to supply a complete vary of care choices that ship higher outcomes, in addition to entry larger quantity and care capabilities throughout the group.”

BrightSpring has two primary service strains below its umbrella: pharmacy and supplier providers.

There is a crucial overlap between these two service strains, Rousseau stated.

“Each affected person of our supplier has an essential medicine administration and routine want,” he stated. “For almost all of our sufferers we serve, we additionally present medicine administration and pharmacy providers in a extra coordinated method. That’s greater than 35,000 extra referrals per yr. That could be a very distinctive functionality set that we consider is totally essential to drive value-based healthcare outcomes sooner or later.”

That’s the state of affairs as it’s now. Over the subsequent 5 or ten years, BrightSpring hopes to profit from the referrals it will probably obtain because it continues to develop.

“Trying forward, there’s a a lot larger alternative,” Rousseau stated. “If we met all of the providers and desires our sufferers have at the moment, it will greater than double the enterprise. There are effectively over 500,000 extra referrals per yr that we may doubtlessly obtain. That’s the objective as we proceed to drive extra built-in care.”

Rousseau doesn’t need BrightSpring to supply extra care sooner or later, as a result of it will probably. It desires to leverage its home-based major care capabilities to serve its sufferers in value-based fashions.

“That's the place we begin to get extra financial advantages from the good outcomes we're reaching daily,” Rousseau stated.

BrightSpring's dwelling medicine program, along with dwelling care, led to a 73% discount in hospital admissions, the report says.

By way of development, the corporate plans to be very aggressive and acquisitive within the coming yr. Rousseau even referred to as his pipeline “as giant and enticing as ever.”

“Lots of people need to promote to our firm,” he stated. “They see us as a winner in the way forward for healthcare and a house for the long run. So we have now super entry. Our pipeline incorporates 100 potential offers at any time. We’re very deliberate and deliberate concerning the offers we make. We have now a number of offers that we anticipate to shut within the interval March and April.”

BrightSpring formally introduced its transfer to go public in January.

Within the fourth quarter of 2023, supplier revenues rose $25 million – or 4.4% – yr over yr to $589 million.

Whole income for the corporate was reported to be $2.4 billion, up 22.1% yr over yr.